Cargando…
Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics
The process of discovering small molecule drugs involves screening numerous compounds and optimizing the most promising ones, both in vitro and in vivo. However, approximately 90% of these optimized candidates fail during trials due to unexpected toxicity or insufficient efficacy. Current concepts w...
Autores principales: | Rao, Mohan, McDuffie, Eric, Sachs, Clifford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611213/ https://www.ncbi.nlm.nih.gov/pubmed/37888725 http://dx.doi.org/10.3390/toxics11100875 |
Ejemplares similares
-
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning
por: Rajput, Akanksha, et al.
Publicado: (2021) -
Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
por: Prasad, Kartikay, et al.
Publicado: (2021) -
Artificial intelligence driven by machine learning and deep learning
por: Zohuri, Bahman, et al.
Publicado: (2020) -
Artificial intelligence in COVID-19 drug repurposing
por: Zhou, Yadi, et al.
Publicado: (2020) -
Application of Artificial Intelligence in COVID-19 drug repurposing
por: Mohanty, Sweta, et al.
Publicado: (2020)